Overview
Tomoyuki Kawamura practices in Hitachi, Japan. Mr. Kawamura is rated as an Experienced expert by MediFind in the treatment of Empyema. His top areas of expertise are Type 1 Diabetes (T1D), Rabson-Mendenhall Syndrome, Maturity Onset Diabetes of the Young, Donohue Syndrome, and Thymectomy.
His clinical research consists of co-authoring 62 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Empyema.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Donohue SyndromeMr. Kawamura isAdvanced. Learn about Donohue Syndrome.
- Maturity Onset Diabetes of the YoungMr. Kawamura isAdvanced. Learn about Maturity Onset Diabetes of the Young.
- Rabson-Mendenhall SyndromeMr. Kawamura isAdvanced. Learn about Rabson-Mendenhall Syndrome.
- Type 1 Diabetes (T1D)Mr. Kawamura isAdvanced. Learn about Type 1 Diabetes (T1D).
- Experienced
- Acute PainMr. Kawamura isExperienced. Learn about Acute Pain.
- Collapsed LungMr. Kawamura isExperienced. Learn about Collapsed Lung.
- Diabetic KetoacidosisMr. Kawamura isExperienced. Learn about Diabetic Ketoacidosis.
- EmpyemaMr. Kawamura isExperienced. Learn about Empyema.
- Infantile PneumothoraxMr. Kawamura isExperienced. Learn about Infantile Pneumothorax.
- Low Blood SugarMr. Kawamura isExperienced. Learn about Low Blood Sugar.